Q1 2026 Oncoclinicas do Brasil Servicos Medicos SA Earnings Call (Portuguese) Transcript
Good morning and welcome to the audio conference of Oncoclinicas.
At this moment, all of our participants are connected only as listeners. Later we will start the question-and-answer session when instructions for you to participate will be given. Please remember that this audio conference is being recorded.
I would like to now pass the microphone to Carlos Gil, CEO of the Oncoclinicas Group.
Carlos Gil, please go ahead.
Good morning. Thank you for all of your presence. I would like to compliment our investors, our analysts and the other participants who are accompanying the release of the results of the first quarter of 2026. It was a quarter that was very challenging for the company, marked by strong operational pressure and financial pressure. We confronted a complex scenario which demands an administration quick decision-making and principally responsibility in the conduction of our operations.
Since the beginning, the priority
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
